Man

Ivanny Carolina Marchant Ramirez

ESCUELA DE MEDICINA UNIVERSIDAD DE VALPARAISO

Valparaiso, Chile

Líneas de Investigación


Human physiology underlying human pharmacokinetics and pharmacodynamics. Cardiovascular disease; Clinical pharmacology; Pathophysiology of arterial hypertension and cardiovascular risk. Translational applied strategies.

Educación

  •  Farmacología clínica, UNIVERSITE CLAUDE BERNARD LYON I. Francia, 2009
  •  Médico-cirujano, UNIVERSIDAD DE VALPARAISO. Chile, 2001
  •  Farmacología clínica, UNIVERSIDAD COMPLUTENSE DE MADRID. España, 2005

Experiencia Académica

  •   Profesor adjunto Full Time

    UNIVERSIDAD DE VALPARAISO

    Medicina

    Viña del Mar, Chile

    2003 - A la fecha

Experiencia Profesional

  •   Médico Servicio Medicina interna Part Time

    Hospital de Quilpué

    Quilpué, Chile

    2002 - 2002

  •   médico general Other

    Sociedad profesional de urgencia cardiológica EMECAR

    Viña del Mar, Chile

    2002 - 2003


 

Article (19)

Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients
Proteostasis and Mitochondrial Role on Psychiatric and Neurodegenerative Disorders: Current Perspectives
Transient Receptor Potential Vanilloid 1 Expression Mediates Capsaicin-Induced Cell Death
[OP.1D.08] SYNERGETIC PREVENTION OF SUDDEN DEATH BY ACEI, STATIN AND GLIFLOZIN IN TYPE 2 DIABETES: A SIMULATION STUDY
Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Perspectives of TRPV1 Function on the Neurogenesis and Neural Plasticity.
TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
Biomarqueur, critère intermédiaire et critère de substitution.
Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population.
Improving risk prediction performance for a better guidelines application
The missed HDL-cholesterol objective, or the failure of CETP inhibitors.
Modeling the impact of cardiovascular prevention strategies: toward better information for public health decisions
Virtual patients and sensitivity analysis of the Guyton model of blood pressure regulation: towards individualized models of whole-body physiology.
The Global Risk Approach should be better applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies
Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum
Blood pressure lowering in the oldest old: a step toward abandoning arbitrary blood pressure targets
SCORE should be preferred to Framingham to predict cardiovascular death in French population
"Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, "ecstasy") exhibit increased ethanol consumption and preference"

Abstract (6)

US cholesterol guidelines do not fit French population
DOES DIABETES REALLY HARM WOMEN MORE THAN MEN? ANALYSES FROM 30560 INDIVIDUAL PATIENT DATA
PUBLIC HEALTH IMPACT OF CARDIOVASCULAR TREATMENTS IN PRIMARY PREVENTION: A SIMULATION STUDY ON A VIRTUAL REALISTIC POPULATION
VALIDATION OF FRAMINGHAM AND SCORE IN 30560 PATIENTS WITH HYPERTENSION
Virtual realistic population: a new tool to illustrate the impact of both drug combination & risk - based patient selection strategies
TOWARDS EQUITABLE STRATEGIES FOR HYPERTENSION MANAGEMENT IN CARDIOVASCULAR PREVENTION

EditorialMaterial (1)

Modeling the impact of cardiovascular prevention strategies: toward better information for public health decisions

Letter (1)

Blood pressure lowering in the oldest old: a step toward abandoning arbitrary blood pressure targets

Review (1)

Perspectives of TRPV1 Function on the Neurogenesis and Neural Plasticity
15
Ivanny Marchant

ESCUELA DE MEDICINA UNIVERSIDAD DE VALPARAISO

Valparaiso, Chile

5
Pablo Olivero

Profesor Adjunto

Patologia y Fisiologia

Universidad de Valparaiso

Viña del Mar, Chile

4
Ricardo Ramírez

Coordinador académico

Universidad Andrés Bello

Viña del Mar, Chile

4
Claudio Cordova

Investigador asistente

Medicina

Universidad de Valparaíso

Valparaíso, Chile

3
carlo lozano

Profesor asociado

Facultad de Medicina

Universidad de Valparaíso

Valparaíso, Chile

2
Belen Rodriguez

Jefa de Calidad

Departamento de Patología

Universidad de Valparaíso

Viña del Mar, Chile

2
Wilfredo González

Profesor Asociado

Patología y Odontología Conservadora

Universidad de Los Andes

Las Condes, Chile

1
Ramón Sotomayor

Full Professor

Institute of Physiology

UNIVERSIDAD DE VALPARAÍSO, FACULTAD DE CIENCIAS, DEPARTAMENTO DE FISIOLOGÍA

Valparaíso, Chile

1
Felipe Simon

Profesor Titular

Department of Biological Sciences

UNIVERSIDAD ANDRES BELLO FAC DE CS BIOLOGICAS, DPTO DE CS BIOLOGICAS

Santiago, Chile

1
Marcelo Arancibia

Principal investigator

Universidad de Valparaíso

Viña del Mar, Chile

1
Horacio Poblete

Profesor Conferenciante

Universidad de Talca

Talca, Chile

1
Nicolas Meza

Asistente de investigación

Escuela de Medicina

Universidad de Valparaíso

Viña del Mar, Chile

1
Pablo Muñoz

UNIVERSIDAD DE VALPARAÍSO

Valparaíso, Chile

1
César Echeverría

DIRECTOR DE INVESTIGACIÓN

Medicina

Universidad de Atacama

COPIAPO, Chile